Member Info for Bella6532

I still think deals are based on Bond reduction...it's an overhang ghey don't like...and thi para serms to hjnt at ssme..

'Upon the earlier of (i) the date on which the Company publishes the data readouts of its Phase 1b trials of faridoxorubicin (FAP-Dox, AVA6000) in triple negative breast cancer and (ii) 30 June 2026, the Bondholder will have the right to accelerate the satisfaction (in cash or shares) of one of both the Deferred Repayments and in addition, from 1 October 2026, at any time accelerate the satisfaction of the quarterly repayments on the Convertible Bond, subject to a maximum of one acceleration per quarter.'

If pattern continues...this will, over next couple of weeks, fall back to around 70 mark...another fundraise will be announced followed by 1b data and SP will move up and knock on 100's door...

5 is what ARM did and it worked very well for a long time...

LDA..Avacta like Thurs RNSs..next Thurs is Thanksgiving!!! CC will surely be taking it as a holiday and most likely 28th too...not a good time for a key data RNS...so if not this werk then we most lkkely will get it first week of Dec...

And don't forget Covid and all it's after affects etc...

82 was broken today..in fact we hit 83.2 at one point.

Https://www.fiercebiotech.com/biotech/genmab-sheds-another-clinical-adc-18b-profoundbio-buy

Nov 17 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Monday it would buy privately held Halda Therapeutics for $3.05 billion in cash, aiming to expand its presence in treatments targeting solid tumors and prostate cancer.

This marks the medtech conglomerate's second major deal this year, after its $14.6 billion acquisition of neurological drug maker Intra-Cellular Therapies in January, reinforcing its push in higher-growth healthcare segments as it navigates the loss of exclusivity for its blockbuster immune disease treatment Stelara.

Back up to 82...if this goes virtically Northward this afternoon then it's a good sign of news demain...

I suspect news has been pending orders being filled.

I know it should not happen but hey this is the real World...

The document is dated November 2025 and should be accurate.

BV...That was with Diagnostics companies.

London Life Sciences Companies to Watch 2025

P12 - Avacta IPO?

P38 - Employees 44 yet CC said in her last video Presentation they were only 20 or so.

I doubt he even knows what Life Sciences are...

Guess that's why we saw the fall back this morning...large order filling...

This is why Avacta need big hitter investors on board...these are the sort of guys who drive/negotiate big bucks deals...

'CAMBRIDGE, Mass. – April 26, 2023 – Orbital Therapeutics, a company focused on enhancing global health by unleashing the full potential of RNA medicines to treat human disease, today announced the successful closing of $270 million Series A financing. The Series A raise was led by ARCH Venture Partners, with participation from initial investors a16z Bio + Health and Newpath Partners, and new investors Abu Dhabi Growth Fund (ADG), Redmile Group, Exor N.V., Invus, Moore Strategic Ventures, iGlobe Platinum Fund Group, Casdin Capital, Agent Capital, Alexandria Venture Investments, Rellim Capital Management, Heritage Medical Systems, and other undisclosed investors.'

Oops! 78...I hope that's a delayed trade...

Sort of agree BV...but this is AIM and other factors come into play here. There's actually no reason for this rise...it's a churn rise not RNS based and yes it will slip back next week. We've been told 1b data will be issued before year end, so that news is a given and potential next uplift. A deal is not a given but the need for more finance is..what that finance form looks like in the new year is another unknown right now.

As I said it's a wait and see.

80 hit BV...albeit a week later than thought...still time to hit the 90 mark be close tomorrow🫣😉

Think outside the box guys...

Avacta will partner AVA6000 to get it through P3 and Licence out everything else.

They are an R&D company not a manufacturer.

They only have 20 odd employees.

By Licencing out they create a protective blanket for longer.

Does anyone think any of our current Partners might in fact be one of the first to cut a deal...

79 hit...onward and upward...